Nutriband announces exercise of warrants at $6.43 for gross proceeds of $5.31M
Source: SeekingAlpha
2025-09-03 16:11:25 ET
More on Nutriband
- Nutriband issued U.S. patent for transdermal abuse deterrent technology
- Seeking Alpha’s Quant Rating on Nutriband
- Historical earnings data for Nutriband
- Financial information for Nutriband
Read the full article on Seeking Alpha
For further details see:
Nutriband announces exercise of warrants at $6.43 for gross proceeds of $5.31M
Nutriband Inc.
NASDAQ: NTRB
NTRB Trading
-5.71% G/L:
$3.9601 Last:
5,763 Volume:
$4.02 Open:
NTRB Latest News
February 17, 2026 09:30:20 am
BioMedNewsBreaks - Nutriband Inc. (NASDAQ: NTRB) Signs Exclusive Costa Rica Distribution Deal for AVERSA Fentanyl and Sports Tape Products
February 17, 2026 07:00:00 am
Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica
January 30, 2026 10:21:43 am
BioMedNewsBreaks - Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) Highlights Board Appointments and AVERSA Fentanyl Milestones From Annual Meeting
January 30, 2026 07:00:00 am
Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points
NTRB Stock Data
$53,812,983
5,818,377
3.93%
5
N/A
Biotechnology & Life Sciences
Healthcare
US
Orlando
